missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ DRG2 Polyclonal Antibody

Description
Immunogen sequence: TKGEVQRSLL EKELESVGIR LNKHKPNIYF KPKKGGGISF NSTVTLTQCS EKLVQLILHE YKIFNAEVLF REDCSPDEFI DVIVGNRVYM PCLYVYNKID QISMEEVDRL A.
3-Phosphoglycerate dehydrogenase (PHGDH; EC 1.1.1.95) catalyzes the transition of 3-phosphoglycerate into 3-phosphohydroxypyruvate, which is the first and rate-limiting step in the phosphorylated pathway of serine biosynthesis, using NAD+/NADH as a cofactor.
Specifications
Specifications
| Antigen | DRG2 |
| Applications | ELISA, Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 2.23 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 50% glycerol and 0.01% thimerosal; pH 7.3 |
| Gene | Drg2 |
| Gene Accession No. | P55039, Q9QXB9 |
| Gene Alias | AI255295; AI461605; developmentally regulated GTP binding protein 2; developmentally regulated GTP-binding protein 2; developmentally-regulated GTP-binding protein 2; DRG2; DRG-2; RGD1562380; TRAFAC GTPase DRG2; Translation factor GTPase DRG2 |
| Gene Symbols | Drg2 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?